BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27171410)

  • 1. Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer.
    Chou CK; Chen SL; Yen AM; Chiu SY; Fann JC; Chiu HM; Chuang SL; Chiang TH; Wu MS; Wu CY; Chia SL; Lee YC; Chiou ST; Chen HH
    PLoS One; 2016; 11(5):e0155276. PubMed ID: 27171410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outreach and Inreach Strategies for Colorectal Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015-2018.
    Castañeda SF; Bharti B; Rojas M; Mercado S; Bearse AM; Camacho J; Lopez MS; Muñoz F; O'Connell S; Liu L; Talavera GA; Gupta S
    Am J Public Health; 2020 Apr; 110(4):587-594. PubMed ID: 32078353
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
    Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
    Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
    Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.
    Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA
    Am J Prev Med; 2017 Sep; 53(3):335-344. PubMed ID: 28427954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from an Evaluation of the Georgia Colorectal Cancer Control Program's Community Education and Outreach Events, 2013.
    Woodruff RC; Hermstad A; Honeycutt S; Brown M; Kegler MC
    J Cancer Educ; 2017 Jun; 32(2):392-400. PubMed ID: 26706465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer in Italy: 2004 survey.
    Zorzi M; Grazzini G; Senore C; Vettorazzi M
    Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organized colorectal cancer screening in integrated health care systems.
    Levin TR; Jamieson L; Burley DA; Reyes J; Oehrli M; Caldwell C
    Epidemiol Rev; 2011; 33():101-10. PubMed ID: 21709143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Desai N; Rich NE; Jain MK; Blackwell JM; Murphy CC; Perryman P; McBryde J; Quirk L; Clark C; Villarreal D; Waljee AK; Gopal P; Singal AG
    Am J Gastroenterol; 2021 May; 116(5):976-983. PubMed ID: 33337657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inreach and outreach interventions to improve mammography use.
    Yabroff KR; O'Malley A; Mangan P; Mandelblatt J
    J Am Med Womens Assoc (1972); 2001; 56(4):166-73, 188. PubMed ID: 11759785
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.